1. Catalog
  2. ORN Fall 2023 - The Evolution of Buprenorphine: Pr ...
Image For Activity Cover
ORN Fall 2023 - The Evolution of Buprenorphine: Prescribing practices and efforts to increase MOUD access
AVAILABLE ON-DEMAND
Available on-demand. Login or create an account to register to view the recording.
Description:
This talk will describe the distribution of buprenorphine patient caseloads for clinicians prescribing formulations of buprenorphine indicated to treat opioid use disorder, how those caseloads evolve over time, and factors associated higher-volume buprenorphine prescribers. The presentation will also discuss implications for expanding access to medication treatment for opioid use disorder and state and federal policy efforts.
Learning Objectives:
At the conclusion of trhe seminar learners will be able to:
  1. To describe growth in buprenorphine prescribers over time
  2. To identify different trajectories of buprenorphine prescribers
  3. To identify policies likely to have influenced
Claim Credits & Course Materials

How to claim your credits & download handouts for each webinar:

Under the "Course" tab (or "Content" tab):
  1. Complete the required course materials.
  2. Claim your credits by clicking the "Report Credit" or "Request Credit" button on the right above the course materials.
Speaker:
Bradely D. Stein, MD

Bradley D. Stein, (M.D. University of Pittsburgh 1995, M.P.H University of Pittsburgh 1997, Ph.D. Health Policy, RAND Graduate School 2002) is a practicing psychiatrist and a Senior Physician Policy Researcher at the RAND Corporation. A health services and policy researcher and clinician experienced in working with individuals with substance use disorders, Dr. Stein's research activities focus on better understanding and improving the quality of care provided to individuals with mental health and substance abuse disorders being treated in community settings. In recent years, much of Dr. Stein's work has focused on the opioid crisis, serving as PI or co-PI on twelve federal and privately funded studies related to the opioid crisis, and he is currently the Director of the NIDA funded Opioid Policy, Tools, and Information Center of Research Excellence. He has testified to Congress on issues related to the opioid crisis, as well as publishing multiple peer reviewed articles in a range of journals including the Journal of the American Medical Association, Health Affairs, the Milbank Quarterly, and Drug and Alcohol Dependence related to the crisis on topics including the treatment of opioid use disorders, the prescribing of opioid analgesics, and the effects of state and federal policies.
Summary
Availability: No future session
Expires on Dec 31, 2024
Cost: FREE
Credit Offered:
1 AMA PRA Category 1 Credit
1 AOA Category 1A Credit
Create Account
Recommended
Powered By